Evidence map›Paper›PMID 41776118›Full record

ArticleAIDS and behavior2026

Factors Associated with Mpox Vaccination Uptake Among Women of Transgender Experience and Transfeminine People in New York City, 2024.

Alexis V Rivera, Kristina Rodriguez, Mimi Shelton, Zoe Edelstein

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexis V RiveraNew York City Department of Health and Mental Hygiene, HIV Epidemiology Program, Bureau of Hepatitis, HIV, and STIs, Queens, NY, USA. arivera6@health.nyc.gov.ORCID http://orcid.org/0000-0003-0423-6902
Kristina RodriguezNew York City Department of Health and Mental Hygiene, HIV Epidemiology Program, Bureau of Hepatitis, HIV, and STIs, Queens, NY, USA.
Mimi SheltonNew York City Department of Health and Mental Hygiene, HIV Epidemiology Program, Bureau of Hepatitis, HIV, and STIs, Queens, NY, USA.
Zoe EdelsteinNew York City Department of Health and Mental Hygiene, HIV Epidemiology Program, Bureau of Hepatitis, HIV, and STIs, Queens, NY, USA.

Funding

CDC HHS CDC 5 NU62PS924775JG CDC HHS CDC 5 NU62PS924775NCHHSTP CDC HHS NU62PS924775
6 · The paper itself

Abstract

Women of transgender experience (WTE) have been disproportionately burdened by mpox. Using 2024 data from the New York City site of the National HIV Behavioral Surveillance study among WTE and transfeminine people (TFP), we identified factors associated with receiving at least one dose of the mpox vaccine. Of 103 WTE/TFP, most identified as Hispanic/Latina and being born outside of the United States with 40% receiving at least one dose. Participants who self-reported having HIV were more than twice as likely to have received a dose (PR: 2.31; 95% CI: 1.20-4.47). Mpox vaccine outreach efforts may benefit from status-neutral strategies.

Indexed as

HIV InfectionsMpox, MonkeypoxSmallpox VaccineTransgender PersonsVaccinationAdultFemaleHumansMaleMiddle AgedNew York CityYoung AdultSmallpox VaccineHIVMpoxVaccineWomen of transgender experience

Identifiers

PMID41776118
PMCPMC13071804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.